Exhausted CD8 T cell progenitors are sustained with TCR engagement during anti-tumor responses

نویسندگان

چکیده

Abstract T cell exhaustion is a major contributor to tumor immune invasion. The durability of an anti-tumor response in part determined by the persistence exhausted CD8 progenitors (Tpex) that reconstitute effector pool. While it has been reported Tpex are able survive without antigen, role TCR engagement regulating self-renewal during progression remains be fully explored. Here, we used Lewis lung carcinoma model where robust or dampened signal was elicited resulting bona fide tumor-infiltrating Tpex. Longitudinal analysis tumor-specific cells revealed stimulation required for formation and maintenance reservoir tumor-draining lymph nodes (tdLNs). Replenishment abrogated suboptimal priming despite generation central memory-like tdLNs. Moreover, attenuated substantially accelerated terminal differentiation optimally primed Chromatin accessibility whole genome DNA methylation profiling Tpex-associated epigenetic programs were significantly enriched engaged Additionally, sub-primed gained more Ets1 motifs while established from acquired greater chromatin at Tcf-1 targeting loci. These targets further validated Tpex-specific when compared those naive cells. Collectively, our results highlight importance sustaining progression.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

TCR down-regulation controls virus-specific CD8+ T cell responses.

The CD3gamma di-leucine-based motif plays a central role in TCR down-regulation. However, little is understood about the role of the CD3gamma di-leucine-based motif in physiological T cell responses. In this study, we show that the expansion in numbers of virus-specific CD8(+) T cells is impaired in mice with a mutated CD3gamma di-leucine-based motif. The CD3gamma mutation did not impair early ...

متن کامل

T Cell Cross-Reactivity and Conformational Changes during TCR Engagement

All thymically selected T cells are inherently cross-reactive, yet many data indicate a fine specificity in antigen recognition, which enables virus escape from immune control by mutation in infections such as the human immunodeficiency virus (HIV). To address this paradox, we analyzed the fine specificity of T cells recognizing a human histocompatibility leukocyte antigen (HLA)-A2-restricted, ...

متن کامل

TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance.

Chimeric antigen receptor (CAR)-expressing T cells induce durable remissions in patients with relapsed/refractory B cell malignancies. CARs are synthetic constructs that, when introduced into mature T cells, confer a second, non-major histocompatibility complex-restricted specificity in addition to the endogenous T cell receptor (TCR). The implications of TCR activation on CAR T cell efficacy h...

متن کامل

PD-1 blockade reverses viral infection-induced loss of anti-tumor CD8+ T cell responses

Background Emerging epidemiologic studies describe an increased prevalence of tumors in patients with non-oncogenic chronic viral disease (e.g., non-AIDS-defining cancers in HIV and non-hepatic cancers in HCV). However, there is a lack of basic understanding by what mechanism infections result in increased unrelated cancer formation (i.e., of cancers in tissues not associated with the infection...

متن کامل

Interleukin-7 Modulates Anti-Tumor CD8+ T Cell Responses via Its Action on Host Cells

The adoptive transfer of antigen-specific CD8+ T cells is a promising approach for the treatment of chronic viral and malignant diseases. In order to improve adoptive T cell therapy (ATT) of cancer, recent strategies aim at the antibody-based blockade of immunosuppressive signaling pathways in CD8+ T cells. Alternatively, adjuvant effects of immunostimulatory cytokines might be exploited to imp...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Immunology

سال: 2023

ISSN: ['1550-6606', '0022-1767']

DOI: https://doi.org/10.4049/jimmunol.210.supp.171.12